
China · Medical devices startup
SceneRay is a Chinese medical device company specializing in brain science, particularly in deep brain stimulation (DBS) and neuromodulation technologies.
Funding reportedLast round: Series D
SceneRay is a Chinese medical device company specializing in brain science, particularly in deep brain stimulation (DBS) and neuromodulation technologies.
Founded in 2011 and headquartered in Suzhou, China, the company focuses on the research, development, production, and sales of DBS systems and related brain-computer-interface medical products. SceneRay's offerings include DBS systems designed for conditions like Parkinson's disease and other dyskinesia-related disorders. The company is also exploring applications for refractory obsessive-compulsive disorder, drug addiction, and alcohol addiction. Notable features of their products include a rechargeable DBS device, dual-target stimulation therapy, and a wireless remote patient programmer. With a strong in-house R&D team and a substantial patent portfolio, SceneRay is committed to advancing clinical solutions for movement disorders and psychiatric conditions through ongoing research and clinical trials.
Funding, as reported
What they build
Known for
health careneurostimulation researchbrain health monitoringimplantable neurostimulatorsneurostimulationneurotech product portfoliomanufacturingclinical neurodevicesneuromedical innovationclinical neurostimulationmedical equipment manufacturingneurostimulation device designrechargeable systemsmedical device manufacturingbrain disorder treatmentneurostimulation system design
Built with from their website
NetEase Enterprise MailWOWConvertViewport MetaVoltagemablMobile FriendlyeGainRuby On RailsjQuery
VHDLGEPRSSSecuritySwiperRubyICPLess
Add your raise, your deck and your story, and put SceneRay in front of investors. Or tell us what we have wrong.